Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

9.120 -0.230 (-2.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
59 60 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today! 
Via InvestorPlace
Novavax, Upstart Holdings And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Novavax, Inc. (NASDAQ: NVAX) fell 30.7% to $39.70 in pre-market trading after the company reported second-quarter revenue decline of 37.6% year-over-year to $185.9 million. The company also lowered its... 
Via Benzinga
Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D. 
Via Benzinga
Novavax Plummets: Covid Vaccine Sales Widely Lag On Unexpected Losses, Slashed Guidance
The company also cut its guidance for 2022 by roughly half. 
Via Investor's Business Daily
Novavax Starts Late-Stage COVID-19 Vaccine Study In Children Below 11 Years
Via Benzinga
U.S. Stock Futures Edge Higher; Crude Oil Drops
Pre-open movers 
Via Benzinga
Novavax, Emerson Electric And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading slightly higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
  
Via Benzinga
Novavax Q2 Results Trail Street Expectations, Slashes FY22 Outlook By 50%
Via Benzinga
Here's What's Going On With Novavax Shares
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 3.05% to $58.43 Monday afternoon in sympathy with BioNTech SE - ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results. 
Via Benzinga
Why Novavax Stock Is Rising Today
Novavax Inc (NASDAQ: NVAX) shares are trading higher Wednesday after the U.S. 
Via Benzinga
Why Novavax Stock Is Surging Today
Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday as CDC advisers meet to discuss the company's COVID-19 vaccine. 
Via Benzinga
S&P 500, Nasdaq Futures Trading Higher As Stocks Look To Continue Strong Rally August 8
The S&P 500 and Nasdaq futures were each up less than 1% heading into the open on Monday, as stocks look to continue their hot streak. As it stands right now, the S&P is up more than 6% in the last... 
Via Benzinga
Disney Leads Media Earnings This Week As Reporting Season Moves Past The Peak
We are past the peak of earnings season, and about 87% of the S&P 500 companies have already released their quarterly numbers, FactSet reports. 
Via Benzinga
Earnings Outlook For Novavax
Novavax (NASDAQ:NVAX) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Novavax will report... 
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients... 
Via Benzinga
Earnings Scheduled For August 8, 2022
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. 
Via Benzinga
Here's Why Novavax Shares Are Moving
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher in sympathy with Moderna Inc (NASDAQ: MRNA), which reported better-than-expected second-quarter results. 
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End of The Day Summary
Via Benzinga
Novavax's COVID-19 Vaccine Gets Back To Back Approval In Japan, Australia For Adolescents
Via Benzinga
S&P 500 Trims Weekly Gain Following Better-Than-Feared Earnings Reports
The SPDR S&P 500 ETF Trust (NYSE: SPY) traded higher on the week as Wall Street digested a batch of earnings reports that were better than feared. 
Via Benzinga
7 Surprising Meme Stocks to Buy and Hold in 2022
All meme stocks are not created equal. While some meme names were only short-term trades, others also boast of sound fundamentals. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
FAZE Stock: 10 Things to Know as FaZe Clan Starts Trading Today
FaZe Clan (FAZE) stock just started trading today after the e-sports team completed a SPAC merger with B. Riley Principal Commercial Capital. 
Via InvestorPlace
The CDC Just Gave Novavax (NVAX) Stock a Big Boost
NVAX stock is getting a lift after the CDC approved Novavax's Covid-19 vaccine for widespread use in adults over the age of 18. 
Via InvestorPlace
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
CDC Advisory Committee Recommends Novavax's COVID-19 Vaccine For Adults
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness... 
Via Benzinga
2 Big Reasons Novavax (NVAX) Stock Is Shooting Higher Today
Novavax has several catalysts igniting NVAX stock higher today. The bulls hope this is just the beginning for NVAX shares. 
Via InvestorPlace
Is it Time to Cash Out Novavax Stock?
Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company’s protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S. 
Via MarketBeat
Exposures COVID-19 Product Safety
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
59 60 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.